NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Leerink Partners

Leerink Partners

Boston, Massachusettsleerink.com

Overview

Leerink Partners is an independent investment bank founded in 1995 with an exclusive focus on the healthcare industry. The firm provides M&A advisory, equity and debt capital markets, equity research, and sales and trading services to companies in the biopharma, digital health, health tech, medical technology, and tools and diagnostics sectors. In addition to its banking services, the firm also engages in investment activities, having co-founded the VC firm Transformation Capital and established the Leerink Transformation Fund. The firm was acquired by SVB Financial Group in 2019 and operated as SVB Leerink and later SVB Securities, before a management buyout in 2023 restored its independence and original name.

Portfolio Companies

32

Investments

Leerink Partners investments
CompanyDateStageLead
Fog PharmaceuticalsJun 2026IPOLead
Alamar BiosciencesApr 2026IPOCo-investor
Kailera TherapeuticsApr 2026IPOLead
Seaport TherapeuticsApr 2026IPOCo-investor
SpyGlass PharmaFeb 2026IPOCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.